XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Net sales $ 593,709 $ 901,711 $ 556,239
Cost of sales 507,449 553,344 417,260
Gross profit 86,260 348,367 138,979
Selling, general and administrative expense 36,580 39,428 38,028
Other (income) expense, net (2,097) 561 (97)
Operating income 51,777 308,378 101,048
Interest expense, net 41,136 46,827 49,378
(Gain) loss on extinguishments of debt (8,644) 113 10,259
Non-operating other (income) expense, net (14,611) (8,083) 2,422
Income before provision (benefit) for income taxes 33,896 269,521 38,989
Provision (benefit) for income taxes 5,973 39,174 (4,556)
Net income 27,923 230,347 43,545
Dividends on convertible preferred stocks     298
Deemed dividend on Series E and Series F redeemable preferred stocks     231,812
Net income (loss) attributable to common stockholders $ 27,923 $ 230,347 $ (220,002)
Basic:      
Net income (loss) $ 0.37 $ 2.72 $ (4.4)
Diluted:      
Net income (loss) $ 0.37 $ 2.68 $ (4.4)
Series E Preferred Stock [Member]      
Dividends on Series E redeemable preferred stock     $ 29,914
Accretion of Series E redeemable preferred stock     $ 1,523